|
1
|
Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme.
|
J Clin Pharmacol
|
2005
|
0.82
|
|
2
|
Reductase-mediated metabolism of motexafin gadolinium (Xcytrin) in rat and human liver subcellular fractions and purified enzyme preparations.
|
J Pharm Sci
|
2005
|
0.79
|
|
3
|
Validation and use of three complementary analytical methods (LC-FLS, LC-MS/MS and ICP-MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues.
|
Anal Bioanal Chem
|
2006
|
0.79
|